Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Kevin Alessandri

Kevin Alessandri

individual
Ecosystem influencer

About

Kevin Alessandri is a French biotech entrepreneur and scientist best known as a co-founder of TreeFrog Therapeutics, a stem-cell manufacturing and cell-therapy company founded in 2018. Public sources describe him in senior operating roles including CEO/CTO in 2019, executive vice president USA in 2021, and CTO in 2022 as the company expanded into Boston and scaled its C-Stem platform. He is also a published scientific author, including on a 2017 Scientific Reports paper related to biomedical imaging tools.

Areas of interest

biotechcell therapystem cellsregenerative medicineimmuno-oncologyParkinson's diseasebiophysicsbioproductionmicrofluidics